The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo.
Mycoplasma synoviae
infection model
pharmacokinetics/pharmacodynamics
tilmicosin
Journal
Journal of veterinary pharmacology and therapeutics
ISSN: 1365-2885
Titre abrégé: J Vet Pharmacol Ther
Pays: England
ID NLM: 7910920
Informations de publication
Date de publication:
12 Aug 2024
12 Aug 2024
Historique:
revised:
01
07
2024
received:
17
04
2024
accepted:
18
07
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
13
8
2024
Statut:
aheadofprint
Résumé
Mycoplasma synoviae (MS) infection is a serious threat to poultry industry in China. Tilmicosin is a semisynthetic macrolide antibiotic used only in animals and has shown potential efficacy against MS, but there were no reported articles concerning the pharmacokinetics/pharmacodynamics (PK/PD) interactions of tilmicosin against MS in vitro and vivo. This study aimed to assess the antibacterial activity of tilmicosin against MS in vitro and in vivo using PK/PD model to provide maximal efficacy. The minimum inhibitory concentration (MIC) and killing rates of different drug concentrations were measured using the microdilution method in vitro. Then, tilmicosin was administered orally to the MS-infected chickens at doses of 7.5 and 60 mg/kg, and the PK parameters of tilmicosin in joint dialysates were determined using high-pressure liquid chromatography/tandem mass spectrometry (HPLC-MS/MS) combined with the microdialysis technique. The antibacterial effect (△E) was calculated when the infected chickens were administered a single oral dose of tilmicosin at 4, 7.5, 15, 30, and 60 mg/kg b.w. The PK and PD data were fitted using the Sigmoid E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Natural Science Foundation of China
ID : 32202866
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Boswell, F., Andrews, J., & Wise, R. (1997). Pharmacodynamic properties of faropenem demonstrated by studies of time‐kill kinetics and postantibiotic effect. The Journal of Antimicrobial Chemotherapy [J], 39, 415–418.
Cayci, M., Kiliç, A. S., Oruc, H. H., & Sarıyev, R. (2019). Screening of veterinary growth‐promoting agent and antibacterial residues in beef cattle and broiler meats consumed in Bursa, Turkey. Journal of Research in Veterinary Medicine [J], 38, 52–58.
Çayci, M., Kiliç, A. S., Oruç, H. H., & Sarıyev, R. (2019). Screening of veterinary growth‐promoting agent and antibacterial residues in beef cattle and broiler meats. Journal of Research in Veterinary Medicine, 38, 52–58.
Chen, Y., Ji, X., Zhang, S., Wang, W., Zhang, H., & Ding, H. (2023). Pharmacokinetic/pharmacodynamic integration of tilmicosin against Pasteurella multocida in a piglet tissue cage model. Frontiers in Veterinary Science, 10, 1260990.
Dimitrova, D., Georgiev, K., Holding, A., & Tsoneva, D. (2012). Pharmacokinetics of tilmicosin in broiler chickens after single oral application. Journal of Mountain Agriculture on the Balkans (Bulgaria), 15(1), 1–12.
Elkomy, A. A., Eltanany, N., Aboubakr, M., Mohamed, Z., & Elbadawy, M. J. (2018). Pharmacokinetics and tissue residues of Tilmicosin in Normal and experimentally mycoplasma Gallisepticum‐infected broiler chickens. Benha Veterinary Medical Journal [J], 5, 11–16.
Elsayed, M., Elkomy, A., Aboubakr, M., & Morad, M. (2014). Tissue residues, hematological and biochemical effects of tilmicosin in broiler chicken. Veterinary Medicine International [J], 2014, 502872.
Garmyn, A., Vereecken, M., de Gussem, K., Depondt, W., Haesebrouck, F., & Martel, A. (2019). Efficacy of Tylosin and Tilmicosin against experimental mycoplasma gallisepticum infection in chickens. Avian Diseases, 63, 359–365.
Gautier‐Bouchardon, A. V. (2018). Antimicrobial resistance in Mycoplasma spp. Microbiology Spectrum, 6, 10–128.
Hammarlund‐Udenaes, M. (2017). Microdialysis as an important technique in systems pharmacology‐a historical and methodological review. The AAPS Journal, 19, 1294–1303.
Hu, Z., Li, H., Zhao, Y., Wang, G., Shang, Y., Chen, Y., Wang, S., Tian, M., Qi, J., & Yu, S. (2022). NADH oxidase of mycoplasma synoviae is a potential diagnostic antigen, plasminogen/fibronectin binding protein and a putative adhesin. BMC Veterinary Research, 18, 455.
Huang, Z., Hu, Z., Zheng, H., Xia, X., Gu, X., Shen, X., Yang, H., & Ding, H. (2020). The PK/PD integration and resistance of Tilmicosin against mycoplasma hyopneumoniae. Pathogens [J], 9, 487.
Huang, Z., Wu, Y., Zhou, Z., Xia, X., Gu, X., Cai, Q., Shen, X., Yang, H., & Ding, H. (2019). Pharmacokinetic and Pharmacodynamic integration and resistance analysis of Tilmicosin against mycoplasma gallisepticum in an in vitro dynamic model. Frontiers in Pharmacology, 10, 670.
Landman, W. J., & Feberwee, A. (2012). Longitudinal field study on the occurrence of mycoplasma synoviae in Dutch Turkey flocks with lameness and experimental induction of the condition. Avian Pathology, 41, 141–149.
Luo, W., Qin, H., Chen, D., Wu, M., Meng, K., Zhang, A., Pan, Y., Qu, W., & Xie, S. (2020). The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic‐pharmacodynamic (PK‐PD) model. Microbial Pathogenesis, 147, 104389.
O'Sullivan, T. L., Johnson, R., Poljak, Z., Gu, Y., DeLay, J., & Friendship, R. M. (2016). An experimental study with a vaccine strain of porcine reproductive and respiratory syndrome virus to determine effects on viremia assessed by reverse transcriptase‐polymerase chain reaction in pigs fed rations medicated with tilmicosin or non‐medicated. Journal of Swine Health and Production [J], 24, 81–92.
Sui, C., Cui, H., Ji, J., Xu, X., Kan, Y., Yao, L., Bi, Y., Zhang, X., & Xie, Q. (2022). Epidemiological investigations and locally determined genotype diversity of mycoplasma synoviae in Central China from 2017 to 2019. Poultry Science, 101, 101522.
Sun, S. K., Lin, X., Chen, F., Wang, D. A., Lu, J. P., Qin, J. P., & Luo, T. R. (2017). Epidemiological investigation of mycoplasma Synoviae in native chicken breeds in China. BMC Veterinary Research, 13, 115.
Toutain, P. L., Pelligand, L., Lees, P., Bousquet‐Mélou, A., Ferran, A. A., & Turnidge, J. D. (2021). The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal. Journal of Veterinary Pharmacology and Therapeutics, 44, 172–200.
Yadav, J. P., Tomar, P., Singh, Y., & Khurana, S. K. (2022). Insights on mycoplasma gallisepticum and mycoplasma synoviae infection in poultry: A systematic review. Animal Biotechnology, 33, 1711–1720.
Yan, X., Liu, J., Jia, Y., Yao, Z., Zhou, M., Song, S., Yuan, S., Zhang, D., & Zhang, N. (2023). The pharmacokinetics of tilmicosin in plasma and joint dialysate in an experimentally mycoplasma synoviae infection model. Poultry Science, 102, 102572.
Yazar, E., Altunok, V., Elmas, M., Traş, B., Baş, A. L., & Özdemir, V. (2002). The effect of tilmicosin on cardiac superoxide dismutase and glutathione peroxidase activities. Journal of veterinary medicine. Series B [J], 49, 209–210.
Yazar, E., Birdane, Y., Elmas, M., Traș, B., & Baș, A. L. (2002). Effect of tilmicosin on serum creatine kinase, creatine kinase‐MB and troponin I levels in New Zealand white rabbits.
Zhang, L., Xie, H., Wang, Y., Wang, H., Hu, J., & Zhang, G. (2022). Pharmacodynamic parameters of pharmacokinetic/Pharmacodynamic (PK/PD) integration models. Frontiers in Veterinary Science, 9, 860472.
Zhang, N., Ba, J., Wang, S., Xu, Z., Wu, F., Li, Z., Deng, H., & Yang, H. (2021). Pharmacokinetics and bioavailability of solid dispersion formulation of tilmicosin in pigs. Journal of Veterinary Pharmacology and Therapeutics, 44, 359–366.
Zhang, N., Liu, Z., Wei, Y., Zhang, C., Mao, C., Cai, Q., Shen, X., & Ding, H. (2020). Comparison of the pharmacokinetics of tilmicosin in plasma and lung tissue in healthy chickens and chickens experimentally infected with mycoplasma gallisepticum. Journal of Veterinary Pharmacology and Therapeutics, 43, 347–354.
Zhang, N., Yan, X., Liu, J., Zhou, S., Zhou, M., Song, S., Yao, Z., Jia, Y., & Yuan, S. (2023). Pharmacokinetics of tilmicosin in chicken joints based on a novel microdialysis sampling method. Journal of Veterinary Pharmacology and Therapeutics, 46, 257–263.
Zhou, Y. F., Bu, M. X., Liu, P., Sun, J., Liu, Y. H., & Liao, X. P. (2020). Epidemiological and PK/PD cutoff values determination and PK/PD‐based dose assessment of gamithromycin against Haemophilus parasuis in piglets. BMC Veterinary Research, 16, 81.